ArticleNature2014
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Lise Boussemart et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
214 papers cite itlatest 60 shown
this paperpooled itcites it
ArticleNature2014
Lise Boussemart et al.PubMed ↗Publisher ↗
No numbers read from the abstract.